查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1530865

2030 年呼吸設備市場預測：按產品類型、疾病/障礙、最終用戶和地區進行的全球分析

Respiratory Devices Market Forecasts to 2030 - Global Analysis By Product Type, Disease/Disorder, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球呼吸設備市場規模將達到 227 億美元，預計到 2030 年將達到 409 億美元，預測期內複合年成長率為 10.3%。呼吸器是醫療設備。這些設備為無法獨立呼吸的患者提供機械通氣，氧氣療法設備提供補充氧氣。呼吸器在急性和慢性環境中都很重要，可以增強呼吸功能、確保充足的氧氣供應並改善患者的治療結果。

根據世界衛生組織統計，2019年約有2.62億人患有氣喘，50萬人死於氣喘。

慢性阻塞性肺病（COPD）盛行率上升

慢性阻塞性肺病是全球發病率和死亡率的主要原因，增加了對人工呼吸器、氧氣濃縮機和霧化器等各種呼吸設備的需求。隨著越來越多的人被診斷出患有慢性阻塞性肺病，對有效管理和治療方案的需求也在增加。呼吸器對於緩解慢性阻塞性肺病患者的症狀、改善肺功能和提高生活品質至關重要。此外，對慢性阻塞性肺病（COPD）的認知和早期診斷的提高進一步推動了這些設備的採用，從而推動市場成長。

副作用和併發症的風險

呼吸設備出現副作用和併發症的風險，例如感染疾病、氣道刺激和設備相關傷害，源於使用不當、設備故障和缺乏適當的維護。這些風險可能會惡化患者的治療效果並降低治療效果。此外，監管監督和需要進行廣泛的臨床試驗來解決這些風險可能會延遲新設備的推出，並進一步阻礙市場擴張。

擴大並改善醫療設施

隨著醫院和診所升級基礎設施，他們擴大投資於尖端呼吸設備，以改善患者護理。改善醫療設施也將改善呼吸系統疾病的診斷和治療，從而推動對人工呼吸器、氧氣療法設備和監測系統等設備的需求。此外，新興市場醫療保健服務的擴展使以前服務不足的人群能夠使用呼吸設備，進一步推動市場成長，並使全球呼吸設備的數量更加可靠。

治療費用高

呼吸設備的高治療成本是由於與這些設備相關的先進技術、製造複雜性和持續維護所造成的。昂貴的零件和研發投資導致價格上漲。因此，這種經濟障礙限制了潛在客戶群並減緩了新技術向服務欠缺地區的滲透，從而抑制了市場成長。有限的價格分佈也會影響整體市場擴張和公平獲得醫療保健的機會。

COVID-19 的影響

COVID-19 的爆發對呼吸設備市場產生了重大影響，推動了對人工呼吸器、氧氣療法機和其他呼吸支援設備的前所未有的需求。 COVID-19 患者的激增使世界各地的醫療保健系統不堪重負，導致這些設備的短缺和產量增加。製造商迅速擴大生產規模以滿足迫切需求。此外，隨著疫情提高了人們對呼吸系統健康的認知、醫療系統為未來的呼吸系統疾病危機做好準備以及個人優先考慮呼吸系統健康，對呼吸設備的需求可能會在大流行後持續存在。

監控設備產業預計在預測期內規模最大

監控設備領域預計將出現良好成長。呼吸監測設備對於評估和管理呼吸健康至關重要。這包括脈搏血氧飽和度分析儀、二氧化碳測量儀和肺活量計。這些設備提供即時資料，允許及時干預和個性化治療計劃。隨著技術的進步，攜帶式且易於使用的監測設備變得越來越可用，改善了患者護理和治療結果。

預計氣喘領域在預測期內複合年成長率最高

預計氣喘細分市場在預測期內將出現最高的複合年成長率。氣喘呼吸裝置對於控制和緩解這種慢性呼吸道疾病的症狀至關重要。這些設備可提高用藥依從性，提供準確的劑量，增強症狀管理，並在氣喘發作期間實現及時介入。透過更好地控制氣喘症狀，這些設備可以幫助改善生活品質，減少氣喘發作頻率，並最大限度地減少對緊急護理的依賴。

比最大的地區

由於呼吸道疾病盛行率上升、污染水平上升和人口老化加劇，預計亞太地區在預測期內將佔據最大的市場佔有率。在大量患者數量和不斷擴大的醫療基礎設施的推動下，中國和印度等國家是主要貢獻者。技術進步和政府改善醫療保健機會的舉措正在進一步推動市場成長。 COVID-19 大流行也增加了該地區對呼吸設備的需求。隨著人們對呼吸健康的認知不斷增強，預計市場在未來幾年將持續擴張。

複合年成長率最高的地區：

北美呼吸設備市場是由慢性阻塞性肺病和氣喘等呼吸系統疾病的高盛行率建立和推動的。先進的醫療基礎設施、高昂的醫療費用以及最尖端科技的廣泛採用正在推動市場的成長。人們對呼吸系統健康的認知不斷提高，加上老年人口的不斷增加，正在推動市場的擴張。美國由於廣泛的研發活動、有利的報銷政策以及主要醫療設備製造商的強大影響力而在市場上佔據主導地位。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球呼吸器材市場：依產品類型

  • 治療設備
    • 氣道通氣裝置
      • 持續性氣道正壓通氣裝置
      • APAP裝置
      • BiPAP 裝置
    • 人工呼吸器
      • 重症監護室人工呼吸器
      • 可攜式/可攜式人工呼吸器
    • 噴霧器
    • 加濕器
    • 氧氣濃縮機
      • 固定式氧氣濃縮機
      • 可攜帶式氧氣設備
    • 吸入器
    • 其他處理設備
  • 監控裝置
    • 脈動式血氧監測儀系統
    • 二氧化碳測量儀
    • 肺計量計
    • 睡眠多項生理檢查儀
    • 峰值流量計
    • 其他監控設備
  • 診斷設備
    • 肺活量測定系統
    • 肺功能檢測儀
    • 血氣分析儀
    • 氧氣濃度測量裝置
    • 其他診斷設備
  • 耗材及配件
    • 面具
    • 呼吸管路
    • 霧化杯
    • 氧氣管
    • 篩選
    • 其他消耗品及配件

第6章全球呼吸設備市場：依疾病/失調分類

  • 急性呼吸衰竭
  • 慢性阻塞性肺病（COPD）
  • 氣喘
  • 睡眠呼吸中止症
  • 囊腫纖維化
  • 新生兒呼吸窘迫症候群
  • 其他呼吸系統疾病

第7章全球呼吸設備市場：依最終用戶分類

  • 醫院
  • 家庭護理設置
  • 日間手術中心 (ASC)
  • 專科診所
  • 其他最終用戶

第8章全球呼吸器材市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第 10 章 公司概況

  • Inogen, Inc.
  • ResMed Inc.
  • Medtronic plc
  • Fisher & Paykel Healthcare Corporation Limited
  • Dragerwerk AG & Co. KGaA
  • GE Healthcare
  • Masimo Corporation
  • Koninklijke Philips NV
  • Invacare Corporation
  • Air Liquide Medical Systems
  • Hamilton Medical AG
  • Vyaire Medical, Inc.
  • Getinge AB
  • Nihon Kohden Corporation
  • Smiths Medical
  • DeVilbiss Healthcare LLC
  • Asahi Kasei Corporation
  • Teleflex Incorporated
Product Code: SMRC26977

According to Stratistics MRC, the Global Respiratory Devices Market is accounted for $22.7 billion in 2024 and is expected to reach $40.9 billion by 2030, growing at a CAGR of 10.3% during the forecast period. Respiratory devices are medical instruments used to assist or support breathing in patients with respiratory conditions. These devices provide mechanical ventilation for patients who cannot breathe independently, and oxygen therapy equipment, which delivers supplemental oxygen. Respiratory devices are critical in both acute and chronic settings, enhancing respiratory function, ensuring adequate oxygenation, and improving patient outcomes.

According to the WHO, in 2019, about 262 million people were suffering and 0.5 million people died from asthma.

Market Dynamics:

Driver:

Rising prevalence of chronic obstructive pulmonary disease (COPD)

COPD, a leading cause of morbidity and mortality worldwide, increases the demand for various respiratory devices such as ventilators, oxygen concentrators, and nebulizers. As more individuals are diagnosed with COPD, the need for effective management and treatment options grows. Respiratory devices are essential in providing symptomatic relief, improving lung function, and enhancing the quality of life for COPD patients. Additionally, increased awareness and early diagnosis of COPD further drive the adoption of these devices, boosting market growth.

Restraint:

Risk of side effects and complications

The risk of side effects and complications in respiratory devices, such as infections, airway irritation, or device-related injuries, stems from improper use, device malfunctions, or lack of proper maintenance. These risks can lead to adverse patient outcomes and diminished effectiveness of treatment. Additionally, regulatory scrutiny and the need for extensive clinical trials to address these risks can slow down the introduction of new devices, further hampering market expansion.

Opportunity:

Expansion and improvement of healthcare facilities

As hospitals and clinics upgrade their infrastructure, they are more likely to invest in state-of-the-art respiratory devices to enhance patient care. Improved healthcare facilities also lead to better diagnosis and treatment of respiratory conditions, driving demand for devices like ventilators, oxygen therapy equipment, and monitoring systems. Additionally, expanding healthcare services in emerging markets brings respiratory devices to previously underserved populations; further boosting market growth and ensuring better respiratory health management globally.

Threat:

High treatment costs

High treatment costs for respiratory devices arise from the advanced technology, manufacturing complexities, and ongoing maintenance associated with these devices. Expensive components and research & development investments contribute to elevated prices. Consequently, this financial barrier hampers market growth by restricting the potential customer base and slowing down the penetration of new technologies into underserved areas. Limited affordability also impacts overall market expansion and equitable healthcare access.

Covid-19 Impact

The covid-19 pandemic significantly impacted the respiratory devices market, driving unprecedented demand for ventilators, oxygen therapy devices, and other respiratory support equipment. The surge in covid-19 cases overwhelmed healthcare systems globally, leading to shortages and increased production of these devices. Manufacturers rapidly scaled up production to meet the urgent need. Additionally, the pandemic raised awareness of respiratory health, potentially leading to sustained demand for respiratory devices even post-pandemic, as healthcare systems prepare for future respiratory crises and individuals prioritize respiratory wellness.

The monitoring devices segment is expected to be the largest during the forecast period

The monitoring devices segment is estimated to have a lucrative growth. Respiratory monitoring devices are crucial for assessing and managing respiratory health. They include pulse oximeters, capnographs, and spirometers. These devices provide real-time data, enabling timely interventions and personalized treatment plans. With advancements in technology, portable and user-friendly monitoring devices are becoming increasingly accessible, enhancing patient care and outcomes.

The asthma segment is expected to have the highest CAGR during the forecast period

The asthma segment is anticipated to witness the highest CAGR growth during the forecast period. Respiratory devices for asthma are essential in managing and alleviating symptoms of this chronic respiratory condition. These devices improve medication adherence, offer precise dosage, enhance symptom management, and enable timely intervention during asthma attacks. By facilitating better control of asthma symptoms, these devices contribute to improved quality of life, reduced frequency of exacerbations, and minimized reliance on emergency care.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period due to increasing prevalence of respiratory diseases, rising pollution levels, and a growing aging population. Countries like China and India are significant contributors, driven by large patient populations and expanding healthcare infrastructure. Technological advancements and government initiatives to improve healthcare access further boost market growth. The COVID-19 pandemic has also heightened demand for respiratory support devices in the region. As awareness of respiratory health increases, the market is expected to see sustained expansion in the coming years.

Region with highest CAGR:

North America respiratory devices market is well-established and driven by high prevalence of respiratory conditions such as COPD and asthma. Advanced healthcare infrastructure, significant healthcare spending, and widespread adoption of cutting-edge technologies contribute to market growth. Increasing awareness about respiratory health, coupled with a growing elderly population, bolsters market expansion. The U.S. dominates the market due to extensive research and development activities, favourable reimbursement policies, and strong presence of major medical device manufacturers.

Key players in the market

Some of the key players profiled in the Respiratory Devices Market include Inogen, Inc., ResMed Inc., Medtronic plc, Fisher & Paykel Healthcare Corporation Limited, Dragerwerk AG & Co. KGaA, GE Healthcare, Masimo Corporation, Koninklijke Philips N.V., Invacare Corporation, Air Liquide Medical Systems, Hamilton Medical AG, Vyaire Medical, Inc., Getinge AB, Nihon Kohden Corporation, Smiths Medical, DeVilbiss Healthcare LLC, Asahi Kasei Corporation and Teleflex Incorporated.

Key Developments:

In August 2023, GE Healthcare launched new wireless patient monitoring device, the CARESCAPE(TM) Remote Monitoring (RM) system. This advanced device is designed to enhance patient care by providing continuous, real-time monitoring of patients' vital signs without the need for wired connections.

In April 2021, Smiths Medical launched the Acapella choice blue vibratory positive expiratory pressure (PEP) therapy system. Acapella is designed to aid in the removal of secretions for patients who have cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.

Product Types Covered:

  • Therapeutic Devices
  • Monitoring Devices
  • Diagnostic Devices
  • Consumables & Accessories

Disease/Disorders Covered:

  • Acute Respiratory Failure
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Sleep Apnea
  • Cystic Fibrosis
  • Neonatal Respiratory Distress Syndrome
  • Other Respiratory Disorders

End Users Covered:

  • Hospitals
  • Homecare Settings
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Respiratory Devices Market, By Product Type

  • 5.1 Introduction
  • 5.2 Therapeutic Devices
    • 5.2.1 PAP Devices
      • 5.2.1.1 CPAP Devices
      • 5.2.1.2 APAP Devices
      • 5.2.1.3 BiPAP Devices
    • 5.2.2 Ventilators
      • 5.2.2.1 ICU Ventilators
      • 5.2.2.2 Portable/Transportable Ventilators
    • 5.2.3 Nebulizers
    • 5.2.4 Humidifiers
    • 5.2.5 Oxygen Concentrators
      • 5.2.5.1 Fixed Oxygen Concentrators
      • 5.2.5.2 Portable Oxygen Concentrators
    • 5.2.6 Inhalers
    • 5.2.7 Other Therapeutic Devices
  • 5.3 Monitoring Devices
    • 5.3.1 Pulse Oximeters
    • 5.3.2 Capnographs
    • 5.3.3 Spirometers
    • 5.3.4 Polysomnography Devices
    • 5.3.5 Peak Flow Meters
    • 5.3.6 Other Monitoring Devices
  • 5.4 Diagnostic Devices
    • 5.4.1 Spirometry Systems
    • 5.4.2 Pulmonary Function Testing Equipment
    • 5.4.3 Blood Gas Analyzers
    • 5.4.4 Oximetry Equipment
    • 5.4.5 Other Diagnostic Devices
  • 5.5 Consumables & Accessories
    • 5.5.1 Masks
    • 5.5.2 Breathing Circuits
    • 5.5.3 Nebulizer Cups
    • 5.5.4 Oxygen Tubing
    • 5.5.5 Filters
    • 5.5.6 Other Consumables & Accessories

6 Global Respiratory Devices Market, By Disease/Disorder

  • 6.1 Introduction
  • 6.2 Acute Respiratory Failure
  • 6.3 Chronic Obstructive Pulmonary Disease (COPD)
  • 6.4 Asthma
  • 6.5 Sleep Apnea
  • 6.6 Cystic Fibrosis
  • 6.7 Neonatal Respiratory Distress Syndrome
  • 6.8 Other Respiratory Disorders

7 Global Respiratory Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Homecare Settings
  • 7.4 Ambulatory Surgical Centers (ASCs)
  • 7.5 Specialty Clinics
  • 7.6 Other End Users

8 Global Respiratory Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Inogen, Inc.
  • 10.2 ResMed Inc.
  • 10.3 Medtronic plc
  • 10.4 Fisher & Paykel Healthcare Corporation Limited
  • 10.5 Dragerwerk AG & Co. KGaA
  • 10.6 GE Healthcare
  • 10.7 Masimo Corporation
  • 10.8 Koninklijke Philips N.V.
  • 10.9 Invacare Corporation
  • 10.10 Air Liquide Medical Systems
  • 10.11 Hamilton Medical AG
  • 10.12 Vyaire Medical, Inc.
  • 10.13 Getinge AB
  • 10.14 Nihon Kohden Corporation
  • 10.15 Smiths Medical
  • 10.16 DeVilbiss Healthcare LLC
  • 10.17 Asahi Kasei Corporation
  • 10.18 Teleflex Incorporated

List of Tables

  • Table 1 Global Respiratory Devices Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Respiratory Devices Market Outlook, By Product Type (2022-2030) ($MN)
  • Table 3 Global Respiratory Devices Market Outlook, By Therapeutic Devices (2022-2030) ($MN)
  • Table 4 Global Respiratory Devices Market Outlook, By PAP Devices (2022-2030) ($MN)
  • Table 5 Global Respiratory Devices Market Outlook, By Ventilators (2022-2030) ($MN)
  • Table 6 Global Respiratory Devices Market Outlook, By Nebulizers (2022-2030) ($MN)
  • Table 7 Global Respiratory Devices Market Outlook, By Humidifiers (2022-2030) ($MN)
  • Table 8 Global Respiratory Devices Market Outlook, By Oxygen Concentrators (2022-2030) ($MN)
  • Table 9 Global Respiratory Devices Market Outlook, By Inhalers (2022-2030) ($MN)
  • Table 10 Global Respiratory Devices Market Outlook, By Other Therapeutic Devices (2022-2030) ($MN)
  • Table 11 Global Respiratory Devices Market Outlook, By Monitoring Devices (2022-2030) ($MN)
  • Table 12 Global Respiratory Devices Market Outlook, By Pulse Oximeters (2022-2030) ($MN)
  • Table 13 Global Respiratory Devices Market Outlook, By Capnographs (2022-2030) ($MN)
  • Table 14 Global Respiratory Devices Market Outlook, By Spirometers (2022-2030) ($MN)
  • Table 15 Global Respiratory Devices Market Outlook, By Polysomnography Devices (2022-2030) ($MN)
  • Table 16 Global Respiratory Devices Market Outlook, By Peak Flow Meters (2022-2030) ($MN)
  • Table 17 Global Respiratory Devices Market Outlook, By Other Monitoring Devices (2022-2030) ($MN)
  • Table 18 Global Respiratory Devices Market Outlook, By Diagnostic Devices (2022-2030) ($MN)
  • Table 19 Global Respiratory Devices Market Outlook, By Spirometry Systems (2022-2030) ($MN)
  • Table 20 Global Respiratory Devices Market Outlook, By Pulmonary Function Testing Equipment (2022-2030) ($MN)
  • Table 21 Global Respiratory Devices Market Outlook, By Blood Gas Analyzers (2022-2030) ($MN)
  • Table 22 Global Respiratory Devices Market Outlook, By Oximetry Equipment (2022-2030) ($MN)
  • Table 23 Global Respiratory Devices Market Outlook, By Other Diagnostic Devices (2022-2030) ($MN)
  • Table 24 Global Respiratory Devices Market Outlook, By Consumables & Accessories (2022-2030) ($MN)
  • Table 25 Global Respiratory Devices Market Outlook, By Masks (2022-2030) ($MN)
  • Table 26 Global Respiratory Devices Market Outlook, By Breathing Circuits (2022-2030) ($MN)
  • Table 27 Global Respiratory Devices Market Outlook, By Nebulizer Cups (2022-2030) ($MN)
  • Table 28 Global Respiratory Devices Market Outlook, By Oxygen Tubing (2022-2030) ($MN)
  • Table 29 Global Respiratory Devices Market Outlook, By Filters (2022-2030) ($MN)
  • Table 30 Global Respiratory Devices Market Outlook, By Other Consumables & Accessories (2022-2030) ($MN)
  • Table 31 Global Respiratory Devices Market Outlook, By Disease/Disorder (2022-2030) ($MN)
  • Table 32 Global Respiratory Devices Market Outlook, By Acute Respiratory Failure (2022-2030) ($MN)
  • Table 33 Global Respiratory Devices Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2022-2030) ($MN)
  • Table 34 Global Respiratory Devices Market Outlook, By Asthma (2022-2030) ($MN)
  • Table 35 Global Respiratory Devices Market Outlook, By Sleep Apnea (2022-2030) ($MN)
  • Table 36 Global Respiratory Devices Market Outlook, By Cystic Fibrosis (2022-2030) ($MN)
  • Table 37 Global Respiratory Devices Market Outlook, By Neonatal Respiratory Distress Syndrome (2022-2030) ($MN)
  • Table 38 Global Respiratory Devices Market Outlook, By Other Respiratory Disorders (2022-2030) ($MN)
  • Table 39 Global Respiratory Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 40 Global Respiratory Devices Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 41 Global Respiratory Devices Market Outlook, By Homecare Settings (2022-2030) ($MN)
  • Table 42 Global Respiratory Devices Market Outlook, By Ambulatory Surgical Centers (ASCs) (2022-2030) ($MN)
  • Table 43 Global Respiratory Devices Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 44 Global Respiratory Devices Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.